PYXIS ONCOLOGY INC. -
1.0700
13-August-25 20:45:00
15 minutes delayed
Stocks
+0.0300
+2.88%
Today's range
1.0171 - 1.1000
ISIN
N/A
Source
NASDAQ
-
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
14 May 2024 04:30:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
09 May 2024 04:30:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
28 Mar 2024 13:30:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights
27 Mar 2024 04:30:00 By Nasdaq GlobeNewswire
-
21 Mar 2024 04:30:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
13 Mar 2024 05:00:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024
07 Mar 2024 13:30:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting
05 Mar 2024 13:45:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Announces $50 Million Private Placement
27 Feb 2024 05:00:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29 Dec 2023 13:30:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
28 Nov 2023 04:00:00 By Nasdaq GlobeNewswire
-
07 Nov 2023 13:30:00 By Nasdaq GlobeNewswire
-
27 Sep 2023 06:18:58 By Nasdaq GlobeNewswire
-
Pyxis Oncology to Participate in Two Upcoming Investment Conferences
31 Aug 2023 13:01:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Successfully Completes Acquisition of Apexigen
23 Aug 2023 05:35:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Reports Financial Results for Second-Quarter 2023 and Provides Corporate Update
11 Aug 2023 04:00:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
30 Jun 2023 14:00:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Advances PYX-106 and PYX-201 Clinical Programs
30 May 2023 05:30:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology to Acquire Apexigen
24 May 2023 03:45:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Reports Financial Results for the First Quarter 2023 and Provides Corporate Update
11 May 2023 04:00:01 By Nasdaq GlobeNewswire